SEC Form 4 · accession 0000899243-17-020218
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles E Sheedy
10% Owner
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 3:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2017 | P | 5,220,000 | $0.2222 | A | 8,286,312 | D | |
| Common StockF1 | holding | — | — | — | 3,365 | I | Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares held in separate trusts for the benefit of children of the Reporting Person (673 shares in each of 5 trusts). The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.